Race Oncology : Notification regarding unquoted securities - RAC
RAC.AX
Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
Announcement Summary
For personal use only
Entity name
RACE ONCOLOGY LTD
Date of this announcement
Friday December 03, 2021
The +securities the subject of this notification are:
+Other securities issued under an +employee incentive scheme that are not intended to be quoted on ASX
Total number of +securities to be issued/transferred
Total number of
ASX +security
+securities to be
code
Security description
issued/transferred
Issue date
New class - code
Unlisted employee options
150,000
03/12/2021
to be confirmed
Refer to next page for full details of the announcement
Notification of Issue, Conversion or Payment up of Unquoted
1 / 7
Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
Part 1 - Entity and announcement details
For personal use only
1.1 Name of entity
RACE ONCOLOGY LTD
We (the entity named above) give notice of the issue, conversion or payment up of the following unquoted +securities.
1.2
Registered number type
Registration number
ABN
61149318749
1.3
ASX issuer code
RAC
3/12/2021
Notification of Issue, Conversion or Payment up of Unquoted
2 / 7
Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
Part 2 - Issue details
2.1 The +securities the subject of this notification are:
+Other securities issued under an +employee incentive scheme that are not intended to be quoted on ASX
For personal use only
2.2a This notification is given in relation to an issue of +securities in a class which is not quoted on ASX and which:
does not have an existing ASX security code ("new class")
Notification of Issue, Conversion or Payment up of Unquoted
3 / 7
Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
Part 3C - number and type of +securities the subject of this notification (new class) where issue has not previously been notified to ASX in an Appendix 3B
only
ASX +security code
+Security description
New class - code to be confirmed
Unlisted employee options
+Security type
ISIN code
Options
use
Date the +securities the subject of this notification were issued
3/12/2021
Will all the +securities issued in this class rank equally in all respects from their issue date?
Yes
Were any of the +securities issued to +key management personnel (KMP) or an +associate?
personal
No
Have you received confirmation from ASX that the terms of the +securities are appropriate and equitable under
listing rule 6.1?
No
Please provide a URL link for a document lodged with ASX setting out the material terms of the +securities being
issued.
The exercise price of the options is $4.77.50,000 options will vest 12 months from the date of issue (First Vesting Date).
Commencing 1 month after the First Vesting Date, 4,166 options will vest on each monthly anniversary of the First Vesting
Date for a 23 month period and 4,182 options will vest on the date which is 24 months from the First Vesting Date. The
options expiry on 3 December 2026.
Options Details
+Security currency
Exercise price
Expiry date
For
AUD - Australian Dollar
AUD 4.77000000
3/12/2026
Details of the existing class of +security that will be issued upon exercise or conversion of this new class of company option
Other
Description
Fully paid ordinary shares
Please provide a URL link for a document lodged with ASX detailing the terms of the +employee incentive scheme or a summary of the terms
https://www.asx.com.au/asx/statistics/displayAnnouncement.do?display=pdf&idsId=02439109
Notification of Issue, Conversion or Payment up of Unquoted
4 / 7
Notification of Issue, Conversion or Payment up of Unquoted Equity Securities
Any other information the entity wishes to provide about the +securities the subject of this notification
N/A
Issue details
For personal use only
Number of +securities
150,000
Notification of Issue, Conversion or Payment up of Unquoted
5 / 7
This is an excerpt of the original content. To continue reading it, access the original document here.
Disclaimer
Race Oncology Ltd. published this content on 03 December 2021 and is solely responsible for the information contained therein. Distributed by Public, unedited and unaltered, on 03 December 2021 06:21:03 UTC.